AI improves stroke and dementia diagnosis in brain scans

New software, created by scientists at Imperial College London and the University of Edinburgh, has been able to identify and measure the severity of small vessel disease, one of the commonest causes of stroke and dementia. The study, published in Radiology, took place at Charing Cross Hospital, part of Imperial College Healthcare NHS Trust.

Photo
Machine learning has detected one of the commonest causes of dementia and stroke, in brain scans (CT), more accurately than current methods
Source: Imperial College London

Researchers say that this technology can help clinicians to administer the best treatment to patients more quickly in emergency settings – and predict a person’s likelihood of developing dementia. The development may also pave the way for more personalised medicine.

Dr Paul Bentley, lead author and Clinical Lecturer at Imperial College London, said: “This is the first time that machine learning methods have been able to accurately measure a marker of small vessel disease in patients presenting with stroke or memory impairment who undergo CT scanning. Our technique is consistent and achieves high accuracy relative to an MRI scan – the current gold standard technique for diagnosis. This could lead to better treatments and care for patients in everyday practice.”

Professor Joanna Wardlaw, Head of Neuroimaging Sciences at the University of Edinburgh, added: “This is a first step in making a scan reading tool that could be useful in mining large routine scan datasets and, after more testing, might aid patient assessment at hospital admission with stroke.”

Small vessel disease (SVD) is a very common neurological disease in older people that reduces blood flow to the deep white matter connections of the brain, damaging and eventually killing the brain cells. It causes stroke and dementia as well as mood disturbance. SVD increases with age but is accelerated by hypertension and diabetes.

At the moment, doctors diagnose SVD by looking for changes to white matter in the brain during MRI or CT scans. However, this relies on a doctor gauging from the scan how far the disease has spread. In CT scans it is often difficult to decide where the edges of the SVD are, making it difficult to estimate the severity of the disease, explains Dr Bentley.

Although MRI can detect and measure SVD more sensitively it is not the most common method used due to scanner availability, and suitability for emergency or older patients.

Dr Bentley added: “Current methods to diagnose the disease through CT or MRI scans can be effective, but it can be difficult for doctors to diagnose the severity of the disease by the human eye. The importance of our new method is that it allows for precise and automated measurement of the disease. This also has applications for widespread diagnosis and monitoring of dementia, as well as for emergency decision-making in stroke.”

Dr Bentley explains that this software could help influence doctors decision-making in emergency neurological conditions and lead to more personalised medicine. For example, in stroke, treatments such as ‘clot busting medications’ can be quickly administered to unblock an artery. However, these treatments can be hazardous by causing bleeding, which becomes more likely as the amount of SVD increases. The software could be applied in future to estimate the likely risk of haemorrhage in patients and doctors can decide on a personal basis, along with other factors, whether to treat or not with clot busters.

He also suggests that the software can help quantify the likelihood of patients developing dementia or immobility, due to slowly progressive SVD. This would alert doctors to potentially reversible causes such as high blood pressure or diabetes.

The study used historical data of 1082 CT scans of stroke patients across 70 hospitals in the UK between 2000-2014, including cases from the Third International Stroke Trial. The software identified and measured a marker of SVD, and then gave a score indicating how severe the disease was ranging from mild to severe. The researchers then compared the results to a panel of expert doctors who estimated SVD severity from the same scans. The level of agreement of the software with the experts was as good as agreements between one expert with another.

Subscribe to our newsletter

Related articles

Machine learning diagnoses COVID-19 from chest CTs

Machine learning diagnoses COVID-19 from chest CTs

Scientists have developed an algorithm for rapid, computerized diagnosis of COVID-19, overcoming the limitations of reverse transcription polymerase chain reaction.

Integrating imaging with deep neural networks

Integrating imaging with deep neural networks

Neural network framework may increase radiologist's confidence in assessing the type of lung cancer on CT scans, informing individualized treatment planning.

COVID-19: AI models not yet suitable for clinical use

COVID-19: AI models not yet suitable for clinical use

Researchers have found that out of the more than 300 COVID-19 machine learning models are not suitable for detecting or diagnosing COVID-19 from standard medical imaging.

How AI can improve medical imaging

How AI can improve medical imaging

AI offers not only the possibility of better detection of a tumor, a skin lesion or some other indication but also can improve accuracy and efficiency for radiologists.

AI system learns to diagnose intracranial hemorrhage

AI system learns to diagnose intracranial hemorrhage

Researchers have developed a system using artificial intelligence to quickly diagnose and classify brain hemorrhages and to provide the basis of its decisions from relatively small image datasets.

Reconstruction of 3D micro-CT images with the help of machine learning

Reconstruction of 3D micro-CT images with the help of machine learning

Researchers have used machine learning to help reconstruct three-dimensional micro-CT images of fibrous materials.

Image fusion method uses AI to improve outcomes

Image fusion method uses AI to improve outcomes

Researchers have developed a new "multi-modal" image fusion method based on supervised deep learning that enhances image clarity, reduces redundant image features and supports batch processing.

Biomedical research: deep learning outperforms machine learning

Biomedical research: deep learning outperforms machine learning

Deep-learning methods have the potential to offer substantially better results, generating superior representations for characterizing the human brain.

Chatbot may detect early dementia in time for intervention

Chatbot may detect early dementia in time for intervention

If Alzheimer's dementia is identified early, the decline in neural functioning can be stabilized or even curtailed in some cases.

Popular articles

Subscribe to Newsletter